Broadway Grosses Analysis: Revival of Sweeney Todd Continues to Bring in the Crowds | Playbill

Grosses Broadway Grosses Analysis: Revival of Sweeney Todd Continues to Bring in the Crowds

See how Broadway performed the week of the 2023 Tony nominations.

Graphic by Vi Dang

The revival of Stephen Sondheim's Sweeney Todd, which was nominated for eight 2023 Tony Awards May 2, continues to be a box-office draw. The production, co-starring Tony nominee Josh Groban and Tony winner Annaleigh Ashford, was the second-highest grossing production of the week ending May 7, taking in $1,826,374 at the box office, over $40,000 more than the previous week. 

Three new Tony-nominated musicals also saw bumps at the box office last week: Some Like It Hot, recipient of 13 Tony nominations, the most of any production of the season ($876,193, up $115,448 from the previous week), New York, New York ($1,019,121, up $75,728), and Shucked ($620,075, up $69,529). And, the Sean Hayes-led Good Night, Oscar—nominated for three Tonys—brought in $702,454, up $62,130.

It was the long-running, Tony-winning Disney musical The Lion King, however, that was the top-grossing production of the week, taking in $1,981,150. Others in the top five included the aforementioned Sweeney Todd, Hamilton ($1,778,225), MJ the Musical ($1,653,203), and Wicked ($1,484,958). Other shows in the Million Dollar Club: Funny Girl ($1,448,544), Moulin Rouge The Musical ($1,250,852), Aladdin ($1,235,940), Harry Potter and the Cursed Child ($1,150,812), Parade ($1,012,351), and & Juliet ($1,007,244). 

Overall, the 34 running Broadway productions took in $30,153,133, a slight dip from the previous week, which had brought in over $31 million with 35 shows on the Main Stem. 

Take a look at the full report here.

The 90s Club
(shows that played to 90% or higher of their seats filled over the entire week):

(10 of 34 currently running productions)

Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting with your ad blocker.
Thank you!